News
46m
Zacks Small Cap Research on MSNENSC Start Phase 3 Trial on Abuse-Resistant Pain RelieverENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the ...
As the opioid epidemic persists across the United States, a team of researchers from Brown University has developed new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results